AI stocks slide on regulation fears while Anthropic's mega-IPO looms — buy quality names into the panic

Verdict: A plausible AI-dip thesis, but no live entry — wait for momentum and the IPO verdict

The thesis — that the AI sell-off reflects regulatory fear rather than weakening demand — has genuine fundamental support over a months-long horizon, but this idea is not ready to trade today. The strongest support is Broadcom's latest quarter (ended August 2, 2026): revenue up 33.4% quarter over quarter to $29.6B with free cash flow up 33.2% to $13.7B, the kind of print you would not expect if AI orders were collapsing. The strongest risk is that the fear is not purely sentiment: per CNBC, AI datacenter stocks slid after the Democratic win, and NVDA's own free cash flow fell 56% to $21.4B in the quarter ended July 26, 2026 even as revenue rose — plus provisional September 30, 2026 ownership filings show net insider open-market selling at all three names. On the strategy side, the single blocking entry condition is five-day momentum: every ticker's five-day rate of change is still negative, so the trade is armed but untriggered, and the setup could not be backtested because the historical price series used inconsistent raw-versus-adjusted bases — no measured edge supports the rule set. Reassess when either a five-day momentum reading turns positive on any of the four tickers, or a confirmed Anthropic IPO date and pricing give the thesis its fast, checkable invalidation test.

Trade now

Wait. The idea's business thesis — that the AI sell-off reflects regulatory fear rather than weakening demand — is not unreasonable on the fundamentals. Broadcom's latest quarter (ended August 2, 2026) showed revenue of $29.6B, up 33.4% quarter over quarter, with net income up 40.6% to $13.1B; Nvidia grew revenue 17.9% to $96.2B; Microsoft grew 2.5% to $92.3B. But a good thesis is not yet a live trade. The entry rule requires, among other things, positive five-day momentum, and as of the November 4, 2026 reading every ticker fails it: AVGO's five-day rate of change is -3.0%, MSFT's is -2.5%, NVDA's is -4.8%, and the SMH semiconductor ETF's is -7.1%. Momentum is still falling, so no entry has triggered. Waiting means, concretely, watching for five-day momentum to turn positive while trend strength holds — the ADX reading is 21.7 on AVGO and 22.6 on MSFT, both above the required 18 — and for price to be either below the lower Bollinger band or crossing back above the band midpoint after dipping below it. AVGO's last close was $332.38 versus a midpoint near $341.36, so a bounce of roughly 2.7% with positive momentum would put the crossover entry in range. If the Anthropic IPO is the catalyst the idea leans on, note that no confirmed date appears in the supplied evidence — do not treat this as time-anchored until a date exists. The downside is twofold. First, the thesis invalidates itself quickly if the IPO flops — the idea says so explicitly — so a weak debut would argue for abandoning the setup, not averaging down. Second, a scope note: this strategy could not be backtested (the historical price data mixed raw and adjusted bases), so no measured historical win rate, drawdown, or parameter validation supports the rule set; the decision rests on the current readings and the thesis alone. Also worth weighing: the provisional September 30, 2026 ownership filings show net open-market insider selling at all three names, including roughly $513.6M at AVGO and $569.5M at NVDA. Risk is capped by the strategy's own rules: a stop at -2% from entry or below the nearest support level, whichever comes first, a +4% take-profit cap, and a 60-day maximum hold. ### Technical details Entry rule set (long, daily bars, applied identically to AVGO, MSFT, NVDA, SMH): Rule 1 (dip entry): five-day rate of change (the percentage price change over five sessions) above 0; ADX (14, a trend-strength gauge) above 18; close below the lower Bollinger band (20-day, 2 standard deviations); Donchian (60) upper channel above 1. Status as of November 4, 2026: ADX met on all four tickers (21.7 AVGO, 22.6 MSFT, 22.5 NVDA, 26.4 SMH); price below the lower band met on all four (AVGO $332.38 vs. a lower band of $341.36; MSFT $520.99 vs. $530.24; NVDA $207.79 vs. $218.15; SMH $518.52 vs. $556.65); momentum above zero failed on all four — this is the single blocking condition. Rule 2 (recovery entry): the day's low touched below the Bollinger midpoint, then the close crossed back above the midpoint, with momentum above 0 and ADX above 18. Status: the crossover is near for AVGO, MSFT, and NVDA (price sits below the midpoint by $8.98, $9.25, and $10.36 respectively), but momentum still fails; SMH is far (about $38.13 below its midpoint). Exits: stop at -2% unrealized or a close below the nearest support and the 78.6% Fibonacci retracement; take-profit at +4% unrealized, the 127.2% Fibonacci extension, or the nearest resistance; a hard time exit after 60 bars. Position sizing is fixed-risk at 2% of the account per position, with a maximum of 25% per name. Reference levels for AVGO: nearest support $330.01, nearest resistance $339.58. The reward-to-risk ratio per the rules is structurally 2:1 at the percentage stops; no historical reward-to-risk statistic is available because the backtest could not be computed.

The Demand Data Says the Panic Is Sentiment, Not Fundamentals

Takeaway: The idea's core claim — that AI demand is intact and the selloff is regulatory fear — is broadly supported by the latest reported fundamentals across all three names, though the catalyst itself (the Anthropic IPO) is not yet confirmed as a success. ### Broadcom's Q3 print is the strongest demand datapoint in the set Broadcom's most recent quarter (ended August 2, 2026) shows revenue of $29.6B, up 33.4% quarter over quarter from $22.2B, with net income up 40.6% to $13.1B and free cash flow up 33.2% to $13.7B. Operating margin expanded 5.3 points to 53.9%. If AI infrastructure demand were genuinely weakening — rather than merely feared — you would not expect a diversified AI chip and networking supplier to accelerate this sharply in a single quarter. This is interpretation on my part, but the causal chain is direct: accelerating revenue means customers are still placing orders, which is the thing the thesis says is intact. ### NVIDIA's top line kept growing even as the stock was sold NVIDIA's quarter ended July 26, 2026 shows revenue of $96.2B, up 17.9% from the prior quarter's $81.6B, with net income of $59.7B and a 75.0% gross margin essentially flat. The latest full-year revenue growth was 73.2%, putting NVIDIA in the top 11% of its 1,131-name IT sector peer group. Orders can be canceled faster than shipped, but a company still booking $96B in a single quarter is not the signature of collapsing AI demand. ### Microsoft shows the buyer side of the capex cycle is still spending Microsoft's fiscal Q1 (ended September 30, 2026) shows revenue of $92.3B, up 2.5% sequentially, with operating cash flow up 4.6% to $58.0B and operating margin expanding 4.65 points to 49.8%. Microsoft is one of the largest AI datacenter buyers; its willingness to absorb $35.8B of capex in a single quarter (the latest reported Q4) and still grow cash flow means hyperscaler AI spending — the revenue pool for NVIDIA, Broadcom and the SMH constituents — has not visibly cut back. ### The IPO catalyst gives the thesis a fast,…

Scores

• Conviction score breakdown: 51
• Thesis support: 65
• Trade readiness: 25
• Risk quality: 45
• Fundamentals trend: 70

Watch items

• AVGO — ROC (5)
• MSFT — ROC (5)
• NVDA — Free cash flow (Q3 FY2026 report)
• SMH — Close vs Bollinger (20) midpoint
• AVGO — Close vs nearest support